Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So should Marker Therapeutics (NASDAQ:MRKR) shareholders be worried about its cash burn?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback